Zusammenfassung
Anstoß zur Erstellung dieses Kapitels gab die Übersichtsarbeit „Hartnäckige Mythen zum Thema BPS – und was davon wirklich stimmt!“ von Prof. Dr. Matthias Oelke und Kollegen, aus der dieses Kapitel zu großen Teilen besteht und deren Autoren wir zu großem Dank verpflichtet sind (Oelke M et al. 2019). Diese Arbeit befasst sich inhaltlich mit gängigen „Lehr- und Expertenmeinungen“, die seit Jahrzehnten durch die konservative und operative BPS-Therapie geistern und schwer aus den Köpfen zu bekommen sind (Level of Evidence 5). Über die hartnäckige Verbreitung dieser Meinungen des „Warum?“ kann man nur spekulieren, da eine Diskrepanz zwischen volkswirtschaftlicher Bedeutung und Evidenz besteht: Das BPS ist in den westlichen Industrienationen die häufigste urologische Erkrankung, die vierthäufigste sowie fünftteuerste Erkrankung bei Männern ≥50 Jahre. Etwa 5 Mio. deutsche Männer sind vom BPS betroffen, von denen sich etwa die Hälfte in ärztlicher Behandlung befindet (Berges RR et al. 2001). Bei durchschnittlichen Kosten für Diagnostik und Therapie von ca. € 900 pro BPS-Patient/Jahr muss das deutsche Gesundheitssystem ca. € 2,2 Mrd./Jahr für das BPS aufwenden (Van Exel NJ et al. 2006). Die steigende Prävalenz des BPS aufgrund des zunehmenden Lebensalters der männlichen Bevölkerung Deutschlands unterstreicht zusätzlich die Bedeutung des BPS.
Aufgrund der epidemiologischen Daten und somit der volkswirtschaftlichen Bedeutung liegt eine wissenschaftliche Fokussierung auf das BPS nahe. Leider ist das Gegenteil der Fall: eine Fokussierung der (deutschen) Urologie auf onkologische Themen. Die Ursachen dafür sind (gesundheitspolitisch) vielschichtig und führen über den Inhalt des Buches hinaus. Zusammenfassend wird das BPS aktuell wissenschaftlich unterrepräsentiert, während BPS-Patienten klinisch überrepräsentiert sind. Möglichweise führt diese Diskrepanz zu dem hartnäckigen Festhalten an „Lehr- und Expertenmeinungen“…auch, wenn diese These schwer zu beweisen ist.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Literatur
Abrams PH, Roylance J, Feneley RC (1976) Excretion urography in the investigation of prostatism. Br J Urol 48:681–684
Abrams PH, Griffiths DJ (1979) The assessment of prostatic obstruction from urodynamic measurements and from residual urine. Br J Urol 51:129–134
Adam C, Hofstetter A, Deubner J et al (2004) Retropubic transvesical prostatectomy for significant prostatic enlargement must remain a standard part of urology training. Scand J Urol Nephrol 38:472–476
Adot Zurbano JM, Salinas Casado J, Metal D (2005) Urodynamics of the bladder diverticulum in the adult male. Arch Esp Urol 58:641–649
Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58:384–397
Anderson JB, Grant JB (1991) Postoperative retention of urine: a prospective urodynamic study. BMJ302:894–896
Antunes AA, Srougi M, Coelho RF et al (2009) Transurethral resection of the prostate for the treatmentof lower urinary tract symptomsrelated to benign prostatichyperplasia: howmuch should be resected? Int Braz JUrol 35:683–689 (discussion 689–691)
Autorino R, Zargar H, Mariano MB et al (2015) Perioperative outcomes of robotic and laparoscopic simple prostatectomy: a European-American multi-institutional analysis. Eur Urol 68:86–94
Berges RR, Pientka L, Höfner K et al (2001) Male lower urinary tract symptoms and related health care seeking in Germany. EurUrol 39:682–687
Bach T, Geavlete B, Pfeiffer D, Wendt-Nordahl G, Michel MS, Gross A (2008) TURP in patients with Biopsy-Proven prostate cancer: sensitivity for cancer detection. Urology 73:100–104. https://doi.org/10.1016/j.urology.2008.06.047
Bach T, Muschter R, Sroka R et al (2012) Laser treatment of benign prostatic obstruction: basics and physical differences. Eur Urol 61:317–325
Bach T, **a SJ, Yang Y et al (2010) Thulium: YAG 2 mum cw laser prostatectomy: where do we stand? World J Urol 28:163–168
Bach T, Wölbling F, Gross AJ, Netsch C, Tauber S, Pottek T, Wülfing C, Brunken C (2016) Prospective assessment of perioperative course in 2648 patients after surgical treatment of benign prostatic obstruction. World J Urol 35:285–292. https://doi.org/10.1007/s00345-016-1866-7 Epub 2016 Jun 4
Bachmann A, Tubaro A, Barber N, d'Ancona F, Muir G, Witzsch U, Grimm MO, Benejam J, Stolzenburg JU, Riddick A, Pahernik S, Roelink H, Ameye F, Saussine C, Bruyère F, Loidl W, Larner T, Gogoi NK, Hindley R, Muschter R, Thorpe A, Shrotri N, Graham S, Hamann M, Miller K, Schostak M, Capitán C, Knispel H, Thomas JA, Bachmann A et al (2015) A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2015 Feb;193(2):570–578
Barabas G, Molstad S (2005) No association between elevated post-void residual volume and bacteriuria in residents of nursing homes. Scand J PrimHealthCare 23:52–56
Berges R, Oelke M (2011) Age-stratified normal values for prostate volume, PSA, maximum urinary flow rate, IPSS, and other LUTS/BPH indicators in the German male community-dwelling population aged 50 years or older. World JUrol 29:171–178
Barry MJ, Cockett AT, Holtgrewe HL et al (1993) Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol 150:351–358
Berry SJ, Coffey DS, Walsh PC et al (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474–479
Bosch JL, Kranse R, Van Mastrigt R et al (1995a) Reasons for the weak correlation between prostate volume and urethral resistance parameters in patients with prostatism. J Urol 153:689–693
Bosch JL, Hop WC, Kirkels WJ et al (1995b) The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptomswith age, prostate volume, flow rate and residual urine volume. Br J Urol 75:622–630
Brookman-May S, Burger M, Hoschke B et al (2010) Association between residual urinary volume and urinary tract infection: prospective trial in 225male patients. Urologe A 49:1163–1168
Bruce A, Krishan A, Sadiq S, Ehsanullah SA, Khashaba S, Bruce A et al (2021) Safety and efficacy of bipolar transurethral resection of the prostate vs monopolar transurethral resection of prostate in the treatment of moderate-large volume prostatichyperplasia: a systematic review and meta-analysis. J Endourol 35(5):663–673
Bruskewitz RC, Iversen P, Madsen PO (1982) Value of postvoid residual urine determination in evaluation of prostatism. Urology 20:602–604
Bruyere F, Puichaud A, Pereira H et al (2010) Influence of photoselective vaporization of the prostate on sexual function: results of a prospective analysis of 149 patients with long-term follow-up. Eur Urol 2010(58):207–211
Crawford ED, Wilson SS, Mcconnell JD et al (2006) Baseline factors as predictors of clinical progression of benign prostatic hyperplasia in men treated with placebo. J Urol 175:1422–1426 (discussion1426–1427)
Chen S, Zhu L, Cai J et al (2014) Plasmakinetic enucleation of the prostate compared with open prostatectomy for prostates larger than 100 grams: a randomized noninferiority controlled trial with long-term results at 6 years. Eur Urol 66:284–291
Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, McVary K, Novara G, Woo H, Madersbacher S (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67:1066–1096
De Nunzio C, Cantiello F, Fiori C, Crocerossa F, Tognoni P, Amparore D, Baldassarri V, Elbers JR, Sancha FG, Porpiglia F (2020) Urinary and sexual function after treatment with temporary implantable nitinol device (iTind®) in men with LUTS: 6-month interim results of the MT-06-study. World Journal of Urology
Donker PJ, Ivanovici F, Noach EL (1972) Analyses of the urethral pressure profile by means of electromyography and the administration of drugs. Br JUrol44:180–193
El Din KE, De Wildt MJ, Rosier PF et al (1996) The correlation between urodynamic and cystoscopic findings in elderlymenwith voiding complaints. J Urol 155:1018–1022
Elkoushy MA, Elshal AM, Elhilali MM (2015a) Holmium laser transurethral incision of the prostate: can prostate size predict the long-term outcome? Can Urol Assoc J 9:248–254
Elkoushy MA, Elshal AM, Elkoushy MM et al (2015b) Incidental prostate cancer diagnosis during holmium laser enucleation: assessment of predictors, survival, and disease progression. Urology 86:552–557
Elmansy HM, Elzayat E, Elhilali MM (2010) Holmium laser ablation versus photoselective vaporization of prostate less than 60 cc: long-term results of a randomized trial. J Urol 184:2023
Elzayat EA, Elhilali MM (2006) Holmium laser enucleation of the prostate (HoLEP): The endourologic alternative to open prostatectomy. Eur Urol 49:87
Enikeev D, Morozov A, Taratkin M, Misrai V, Rijo E, Podoinitsin A, Gabdullina S, Herrmann TRW (2021) Systematic review of the endoscopic enucleation of the prostate learning curve. World J Urol 2021(39):2427–2438
Fraundorfer MR, Gilling PJ (1998). Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol 33:69–72
Furuya S, Kumamoto Y, Yokoyama E et al (1982) Alpha-adrenergic activity and urethral pressure in prostatic zone in benign prostatic hypertrophy. J Urol 128:836–839
Furuya S, Furuya R, Ogura H, Araki T, Arita T (2006) A study of 4,031 patients of transurethral resection of the prostate performed by one surgeon: learning curve, surgical results and postoperative complications. Hinyokika Kiyo 52:609–614
Fusco F, Palmieri A, Ficarra V et al (2016) alpha1-blockers improve benign prostatic obstruction in men with lower urinary tract symptoms: a systematic review and meta-analysis of urodynamic studies. EurUrol 69:1091–1101
Geavlete B, Stanescu F, Iacoboaie C et al (2013) Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases – a medium term, prospective, randomized comparison. BJU Int 111:793–803
Gilfrich C, Leicht H, Fahlenbrach C, Jeschke E, Popken G, Stolzenburg JU, Weißbach L, Zastrow C, Günster C (2016) Morbidity and mortality after surgery for lower urinary tract symptoms: a study of 95 577 cases from a nationwide German health insurance database. Prostate Cancer Prostatic Dis. 19:406–411
Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, Kramolowsky E, Thomas A, Cowan B, Kaufman RP, Trainer A, Arther A, Badlani G, Plante M, Desai M, Doumanian L, Te AE, DeGuenther M, Roehrborn C (2020) Three-year outcomes after Aquablation therapy compared to TUR-P: results from a blinded randomized trial. Can J Urol 27:10072–10079
Girman CJ, Jacobsen SJ, Guess HA et al (1995) Natural history of prostatism: relationship among symptoms, prostate volume andpeakurinary flow rate. J Urol 153:1510–1515
Gross AJ, Netsch C, Knipper S, Hölzel J, Bach T (2013) Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution. Eur Urol 63:859–867
Gosling JA, Dixon JS (1980) Structure of trabeculated detrusor smooth muscle in cases of prostatic hypertrophy. Urol Int 35:351–355
Gratzke C, Schlenker B, Seitz M et al (2007) Complications and early postoperative outcome after open prostatectomy in patients with benign prostatic enlargement: results of a prospective multicenter study. J Urol 177:1419–1422
Gravas S, Bach T, Bachmann A, Drake M, Gacci M, Gratzke C, Madersbacher S, Mamoulakis S, Tikkinen KAO (2016) Guidelines on the management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO) EAU; http://uroweb.org/guideline/treatment-of-non-neurogenicmale-luts/. Zugegriffen: Mar 2016
Hald T (1989) Urodynamics in benign prostatic hyperplasia: a survey. Prostate Suppl 2:69–77
Herlemann A, Wegner K, Roosen A, Buchner A, Weinhold P, Bachmann A, Stief CG, Gratzke C, Magistro G (2017) „Finding the needle in a haystack“: oncologic evaluation of patients treated for LUTS with holmium laser enucleation of the prostate (HoLEP) versus transurethral resection of the prostate (TURP). World J Urol 35:1777–1782
Hiraoka Y, Akimoto M (1989) Transurethral enucleation of benign prostatic hyperplasia. J Urol 1989(142):1247–1250
Hong SK, Lee ST, Jeong SJ et al (2010) Chronic kidney disease among men with lower urinary tract symptoms due to benign prostatic hyperplasia. BJUInt 105:1424–1428
Jakobsen H, Torp-Pedersen S, Juul N (1988) Ultrasonic evaluation of age-related human prostatic growth and development of benign prostatic hyperplasia. Scand J Urol Nephrol Suppl 107:26–31
John H, Wagner C, Padevit C, Witt JH (2021a) From open simple to robotic-assisted simple prostatectomy (RASP) for large benign prostate hyperplasia: the time has come. World J Urol
John H, Wagner C, Padevit C, Witt JH (2021b) From open simple to robotic-assisted simple prostatectomy (RASP) for large benign prostate hyperplasia: the time has come. World J Urol. https://doi.org/10.1007/s00345-020-03508-1
Kang M, Kim M, Choo MS et al (2016) Urodynamic features and significant predictors of bladder outlet obstruction in patients with lower urinary tract symptoms/benign prostatic hyperplasia and smallprostate volume. Urology 89:96–102
Kaplan SA, Wein AJ, Staskin DR et al (2008) Urinary retention and post-void residual urine in men: separating truth from tradition. J Urol 180:47–54
Kaplan-Marans E, Martinez M, Wood A, Cochran J, Dubowitch E, Schulman A. Kaplan-Marans E et al (2021) Aquablation, prostatic urethral lift, and transurethral water vapor therapy: a comparison of device related adverse events in a national registry. J Endourol. Jul 27. https://doi.org/10.1089/end.2021.0455. Online ahead of print
Ko DS, Fenster HN, Chambers K et al (1995) The correlation ofmultichannel urodynamic pressureflowstudies and American Urological Association symptom index in the evaluation of benign prostatichyperplasia. J Urol 154:396–398
Krambeck AE, Handa SE, Lingeman JE (2010) Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol 183:1105–1109
Kuo RL, Kim SC, Lingeman JE, Paterson RF, Watkins SL, Simmons GR, Steele RE (2003) Holmium laser enucleation of prostate (HoLEP): the Methodist Hospital experience with greater than 75 gram enucleations. J Urol 170:149–152
Lourenco T, Shaw M, Fraser C et al (2010) The clinical effectiveness of transurethral incision of the prostate: a systematic review of randomised controlled trials.World J Urol 28:23–32
Madersbacher S, Lackner J, Brössner C, Röhlich M, Stancik I, Willinger M, Schatzl G; Prostate Study Group of the Austrian Society of Urology (2005) Reoperation, myocardial infarction and mortality after transurethral and open prostatectomy: a nation-wide, long-term analysis of 23,123 cases. Eur Urol 47:499–504
Mauermayer W (1981) Transurethrale Operationen. Springer, Berlin, Heidelberg, NewYork
McVary KT, Gittelman MC, Goldberg KA, Patel K, Shore ND, Levin RM, Pliskin M, Beahrs JR, Prall D, Kaminetsky J, Cowan BE, Cantrill CH, Mynderse LA, Ulchaker JC, Tadros NN, Gange SN, Roehrborn CG (2021). Final 5-Year Outcomes of the Multicenter Randomized Sham-Controlled Trial of Rezum® Water Vapor Thermal Therapy for Treatment of Moderate-To-Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol: 101097JU0000000000001778
Montorsi F, Naspro R, Salonia A, Suardi N, Briganti A, Zanoni M, Valenti S, Vavassori I, Rigatti P (2004) Holmium laser enucleation versus transurethral resection of the prostate: results from a 2-center, prospective, randomized trial in patients with obstructive benign prostatic hyperplasia. J Urol 172:1926–1929
Naspro R, Suardi N, Salonia A, Scattoni V, Guazzoni G, Colombo R, Cestari A, Briganti A, Mazzoccoli B, Rigatti P, Montorsi F (2006) Holmium laser enucleation of the prostate versus open prostatectomy for prostates >70 g: 24-month follow-up. Eur Urol 50:563–568
Oelke M, Baard J, Wijkstra H et al (2008) Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Eur Urol 54:419–426
Oelke M, Kirschner-Hermanns R, Thiruchelvam N et al (2012) Can we identify men who will have complications from benign prostatic obstruction (BPO)? ICI-RS2011.Neurourol Urodyn31:322–326
Oelke M, Bschleipfer T, Höfner K (2019) Fake News BPH - what is really true!. Urologe A 58:271–283. doi: https://doi.org/10.1007/s00120-019-0885-6
Omli R, Skotnes LH, Mykletun A et al (2008) Residual urine as a risk factor for lower urinary tract infection: a 1-year follow-up study in nursing homes. J Am Geriatr Soc 56:871–874
Ou R, Deng X, Yang W (2013) Transurethral enucleation and resection of the prostate vs transvesical prostatectomy for prostate volumes >80 mL: a prospective randomized study. BJU Int 112:239–245
Osman NI, Chapple CR, Abrams P et al (2014) Detrusor underactivity and the underactive bladder: a new clinical entity? A review of current terminology, definitions, epidemiology, aetiology, anddiagnosis. Eur Urol 65:389–398
Rao J-M, Yang J-R, Ren Y-X et al (2013) Plasmakinetic enucleation of the prostate versus transvesical open prostatectomy for benign prostatic hyperplasia >80 mL: 12-month follow-up results of a randomized clinical trial. Urology 82:176–181
Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, Lack N, Stief CG, Urology Section of the Bavarian Working Group for Quality Assurance (2008) Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol 180:246–249
Roehrborn CG, Barkin J, Gange SN, Shore ND, Giddens JL, Bolton DM, Cowan BE, Cantwell AL, McVary KT, Te AE, Gholami SS, Moseley WG, Chin PT, Dowling WT, Freedman SJ, Incze PF, Coffield KS, Herron S, Rashid P, Rukstalis DB (2017) Five year results of the prospective randomized controlled prostatic urethral L.I.F.T. study. Can J Urol 24:8802–8813
Rom M, Waldert M, Klingler HC et al (2013) Bladder outlet obstruction in men with acute urinary retention: an urodynamic study. World J Urol 31:1045–1050
Rosier PF, De La Rosette JJ (1995) Is there a correlation between prostate size and bladderoutletobstruction? World J Urol 13:9–13
Rule AD, Lieber MM, Jacobsen SJ (2005) Is benign prostatic hyperplasia a risk factor for chronic renal failure? JUrol173:691–696
Ruszat R, Seitz M, Wyler SF et al (2008) GreenLight laser vaporisation of the prostate: single-center experience and longterm results after 500 procedures. Eur Urol 54:893
Swyer GI (1944) Post-natal growth changes in the humanprostate. J Anat 78:130–145
Te AE, Malloy TR, Stein BS et al (2006) Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years. BJU Int 97:1229
Thomas AW, Cannon A, Bartlett E et al (2004) The natural history of lower urinary tract dysfunction in men: the influence of detrusor underactivity on the outcome after transurethral resection of the prostatewith a minimum10-year urodynamic follow-up. BJU Int 93:745–750
Thomas AW, Cannon A, Bartlett E et al (2005) The natural history of lower urinary tract dysfunction in men: minimum 10-year urodynamic followup of untreated detrusor underactivity. BJU Int 96:1295–1300
Thomas JA, Tubaro A, Barber N, d’Ancona F, Muir G, Witzsch U, Grimm MO, Benejam J, Stolzenburg JU, Riddick A, Pahernik S, Roelink H, Ameye F, Saussine C, Bruyere F, Loidl W, Larner T, Gogoi NK, Hindley R, Muschter R, Thorpe A, Shrotri N, Graham S, Hamann M, Miller K, Schostak M, Capitan C, Knispel H, Bachmann A (2016) A multicenter randomized noninferiority trial comparing greenlight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH study. Eur Urol 69:94–102
Umari P, Fossati N, Gandaglia G et al (2017) Robotic assisted simple prostatectomy versus holmium laser enucleation of the prostate for lower urinary tract symptoms in patients with large volume prostate: a comparative analysis from a high volume center. J Urol 197:1108–1114
Van De Beek C, Rollema HJ, Van Mastrigt R et al (1992) Objective analysis of infravesical obstruction and detrusor contractility; appraisal of the computer program Dx/CLIM and Schäfer nomogram.Neurourol Urodyn1:394–395
Van Exel NJ, Koopmanschap MA, McDonnell J et al (2006) Medical consumption and costs during a one-year follow-up of patientswith LUTS suggestive of BPH in six europeancountries: report of the TRIUMPH study. Eur Urol 49:92–102
Varkarakis I, Kyriakakis Z, Delis A et al (2004) Long-term results of open transvesical prostatectomy from a contemporary series of patients. Urology 64:306
Yalla SV, SullivanMP, Lecamwasam HS et al (1995) Correlation of American Urological Association symptomindex with obstructive and nonobstructive prostatism. J Urol 153:674–679 (discussion 679–680)
Yamaçake KG, Nakano ET, Soares IB, Cordeiro P, Srougi M, Antunes AA,Yamaçake KG et al (2015). Analysis of the learning curve for transurethral resection of the prostate. Is there any influence of musical instrument and video game skills on surgical performance? Turk J Urol; 41:132–7
Weiss JK, Santucci NM, Sajadi KP, Chouhan JD (2021) Post-surgical complications after bladder outlet reducing surgery: an analysis of the FDA Manufacturer and User Facility Device Experience (MAUDE) database. Urology 156:211–215. https://doi.org/10.1016/j.urology.2021.04.030
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Der/die Autor(en), exklusiv lizenziert an Springer-Verlag GmbH, DE, ein Teil von Springer Nature
About this chapter
Cite this chapter
Netsch, C., Gross, A.J. (2022). Kontroversen in der konservativen und operativen BPS-Therapie. In: Netsch, C., Gross, A.J. (eds) Benignes Prostatasyndrom. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-64334-1_23
Download citation
DOI: https://doi.org/10.1007/978-3-662-64334-1_23
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-64333-4
Online ISBN: 978-3-662-64334-1
eBook Packages: Medicine (German Language)